Ocugen wins orphan drug status for ocular gene therapy
The FDA has given Ocugen orphan drug status for a gene therapy designed to treat NR2E3 mutation-associated retinal degenerative disease. The Malvern, Penn.-based company’s OCU400 product includes an adeno-associated virum serotype 5 capsid that contains the gene for human nuclear hormone receptor NR2E3. Get the full story at our sister site, Drug Delivery Business News. The post Ocugen wins orphan drug status for ocular gene therapy appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 14, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Pharmaceuticals Regulatory/Compliance ocugen Source Type: news

As Portland-area measles numbers hold steady, critics call for Facebook to keep closer watch on anti-vaccination groups
Amid measles outbreaks and the World Health Organization announcing anti-vaxxers pose a global health threat, Facebook is drawing criticism for the proliferation of anti-immunization groups on the social media platform.   The Guardian reports that the groups promote alternatives to vaccines, like high doses of vitamin C to fight communicable diseases, or vitamin A to ward off measles. Some groups have tens of thousands of members and are closed, which means new members must be approved before joining.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 13, 2019 Category: Pharmaceuticals Authors: Caitlin Mullen Source Type: news

As Portland-area measles numbers hold steady, critics call for Facebook to keep closer watch on anti-vaccination groups
Amid measles outbreaks and the World Health Organization announcing anti-vaxxers pose a global health threat, Facebook is drawing criticism for the proliferation of anti-immunization groups on the social media platform.   The Guardian reports that the groups promote alternatives to vaccines, like high doses of vitamin C to fight communicable diseases, or vitamin A to ward off measles. Some groups have tens of thousands of members and are closed, which means new members must be approved before joining.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 13, 2019 Category: Biotechnology Authors: Caitlin Mullen Source Type: news

Critics call for Facebook to keep closer watch on anti-vaccination groups
Amid measles outbreaks and the World Health Organization announcing anti-vaxxers pose a global health threat, Facebook is drawing criticism for the proliferation of anti-immunization groups on the social media platform.   The Guardian reports that the groups promote alternatives to vaccines, like high doses of vitamin C to fight communicable diseases, or vitamin A to ward off measles. Some groups have tens of thousands of members and are closed, which means new members must be approved before joining.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 13, 2019 Category: Biotechnology Authors: Caitlin Mullen Source Type: news

Inflammation, necrosis, and the kinase RIP3 are key mediators of AAG-dependent alkylation-induced retinal degeneration
DNA-alkylating agents are commonly used to kill cancer cells, but the base excision repair (BER) pathway they trigger can also produce toxic intermediates that cause tissue damage, such as retinal degeneration (RD). Apoptosis, a process of programmed cell death, is assumed to be the main mechanism of this alkylation-induced photoreceptor (PR) cell death in RD. Here, we studied the involvement of necroptosis (another programmed cell death process) and inflammation in alkylation-induced RD. Male mice exposed to a methylating agent exhibited a reduced number of PR cell rows, active gliosis, and cytokine induction and macropha...
Source: Signal Transduction Knowledge Environment - February 12, 2019 Category: Science Authors: Allocca, M., Corrigan, J. J., Mazumder, A., Fake, K. R., Samson, L. D. Tags: STKE Research Articles Source Type: news

Gambia: Meningitis Vaccination Campaign Gets Underway
[Foroyaa] The2019 campaign against Meningitis A with Vitamin A supplementation and deworming, has commenced nationwide on Saturday February 3rd 2019. The campaign is meant to protect children against Meningitis, vitamin A deficiency and worm infestation. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 5, 2019 Category: African Health Source Type: news

Vitamin or Mineral Supplements Don ’ t Prevent Dementia
B vitamins; beta carotene; vitamins C, D or E; zinc, copper or selenium — none proved effective in preventing cognitive decline. (Source: NYT Health)
Source: NYT Health - February 4, 2019 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Vitamins Antioxidants Selenium (Element) Dementia Source Type: news

Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases
(Source: Johnson and Johnson)
Source: Johnson and Johnson - January 31, 2019 Category: Pharmaceuticals Source Type: news

New treatment target emerging for retinal damage
(Medical College of Georgia at Augusta University) Scientists at the Medical College of Georgia at Augusta University are looking at new treatment targets for the retinal damage that often accompanies diseases like diabetes, glaucoma and hypertension. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 31, 2019 Category: International Medicine & Public Health Source Type: news

Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Addition of Phase 3-Ready Clinical Program Orphan Drug Designation for Proliferative Vitreoretinopathy, A Potentially Blinding Disease with No Approved Treatment Initial Clinical Trial Results Expected in 2020 LEXINGTON, Mass., Jan. 29, 2019 -- (H... Biopharmaceuticals, Ophthalmology, Mergers & Acquisitions Aldeyra Therapeutics, Helio Vision, Vitreoretinopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2019 Category: Pharmaceuticals Source Type: news

Patch replaces damaged retinal cells
Researchers developed a biodegradable patch for replacing diseased cells in the eye with healthy ones. The findings provide the basis for preliminary safety tests of the method in people. (Source: NIH Research Matters)
Source: NIH Research Matters - January 29, 2019 Category: Research Source Type: news

What Are Common Causes of Blindness in Children?
Discussion According to the World Health Organization, about 1.3 billion people have some form of visual impairment. Most people with visual impairments are>50 years old, more are female than male, and more live in resource-limited areas than resource-rich areas. Most visual impairments are avoidable (80%) in all age groups with the leading causes globally and across ages being uncorrected refractive errors and cataracts. The most common causes of blindness are: Refractive errors, uncorrected Cataract Age-related macular degeneration Glaucoma Diabetic retinopathy Corneal opacity Trachoma The exact numbers vary by regi...
Source: PediatricEducation.org - January 28, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Nanoscope Receives NIH grants to recruit talent and advance optogenetic delivery platforms
(Nanoscope Technologies) Scientists at Nanoscope have developed gene therapy based on ambient light activatable Multi-Characteristic Opsin (MCO) for vision restoration in patients with retinal degeneration. NanoScope has been awarded several R01 grants from NIH for advancing both viral and non-viral delivery of MCO. Nanoscope recently received multiple Supplemental grants to recruit diverse talent for its Optogenetics and gene delivery programs. This is in addition to the recently awarded R01 and Phase2-SBIR grants to advance its optogenetics approach (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 25, 2019 Category: Biology Source Type: news

2019 Louis-Jeantet Prize for Medicine awarded to Botond Roska
(Institute of Molecular and Clinical Ophthalmology Basel) Botond Roska is awarded the 2019 Louis-Jeantet Prize for Medicine 2019, for the discovery of basic principles of visual information processing and the development of therapeutic strategies, such as gene therapy, to restore vision in retinal disorders. As one of the best-endowed awards in Europe (CHF 500,000 for each prize), the Louis-Jeantet Prizes foster scientific excellence. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 22, 2019 Category: International Medicine & Public Health Source Type: news

Eritrea: NRS - Successful Measles and Rubella Vaccination Program
[Shabait] Massawa. -At an assessment meeting conducted in Massawa on 17 January it was reported that successful measles and rubella vaccination and Vitamin A distribution was conducted in the Northern Red Sea region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 21, 2019 Category: African Health Source Type: news

Traumatic retinal detachment caused by nerf gun shot in a pediatric patient - Mandviwala MM, Sassani PP.
PURPOSE: To present a case of retinal detachment caused by a Nerf-gun shot in a pediatric patient. METHODS: Single case report. RESULTS: A 16-year-old white man presented with a nasal visual field deficit and floaters in his left eye for 1 ... (Source: SafetyLit)
Source: SafetyLit - January 16, 2019 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Eritrea: Successful Measles and Rubella Vaccination
[Shabait] Barentu -At an assessment meeting conducted in Barentu on 13 January it was reported that successful measles and rubella vaccination and Vitamin A distribution was conducted in the Gash Barka region through strong participation of the public and stakeholders. The vaccination program was conducted from 21 to 30 November 2018. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 16, 2019 Category: African Health Source Type: news

Protective effects of ADM-RAMP2 system make it a new therapeutic target for retinal vein occlusion
(Elsevier) A clot in the retinal vein can lead to severe and irreversible loss of vision. In a report in The American Journal of Pathology investigators utilize a newly developed model of central retinal vein occlusion (CRVO) in mice that mimics many of the clinical features of CRVO in humans to study the pathologic effects of retinal occlusion and demonstrate the retinoprotective effects of the peptide adrenomedullin (ADM) and its receptor activity-modifying protein RAMP2. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 15, 2019 Category: International Medicine & Public Health Source Type: news

NIH researchers rescue photoreceptors, prevent blindness in animal models of retinal degeneration
Findings set stage for first clinical trial of stem cell-based therapeutic approach for AMD. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - January 14, 2019 Category: American Health Source Type: news

SightGlass Vision launches trial for pediatric myopia-controlling eyeglasses
Opthalmalogical device maker SightGlass Vision said yesterday that it launched a pivotal clinical trial exploring the use of its novel lenses designed to reduce the rate of progression in children between six and nine years old. The Palo Alto, Calif.-based company’s Cypress trial is a multicenter, double-blinded, randomized controlled clinical trial that aims to enroll 255 patients across 14 clinical sites in the U.S. and Canada. The primary endpoint of the trial is the progression of myopia over 36 months, the company said. SightGlass Visions’s lenses are intended to reduce the progression of myopia, something...
Source: Mass Device - January 11, 2019 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic sightglassvision Source Type: news

Are Sweet Potatoes Healthy? Here ’s What Experts Say
Sweet potatoes pack the unique health benefits of regular potatoes with a little something extra. “In general, the more color you can add into your diet coming from fruits and vegetables, the better,” says Yasi Ansari, a sports dietitian in Los Angeles and San Francisco. Still, the many nutritional benefits are no excuse to spring for sweet potato fries at every chance. Here’s what you need to know about how healthy sweet potatoes are, plus the best ways to incorporate them into any diet. What are the nutritional benefits of sweet potatoes? “All potatoes are nutrient-dense and healthy for you,&rdquo...
Source: TIME: Health - January 10, 2019 Category: Consumer Health News Authors: Cassie Shortsleeve  Tags: Uncategorized Diet/Nutrition Source Type: news

Medical News Today: Immune system vs. gut bacteria: How vitamin A 'keeps the peace'
New research illuminates the vital role that moderate levels of vitamin A have in preventing the immune system from attacking the bacteria in our guts. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 3, 2019 Category: Consumer Health News Tags: GastroIntestinal / Gastroenterology Source Type: news

New Acne Treatment Might Spring From Isotretinoin (Myorisan)
THURSDAY, Jan. 3, 2019 -- An old acne drug may hold the key to developing a new, safer treatment, a study suggests. Isotretinoin (Myorisan, formerly branded as Accutane), is a form of vitamin A, and has been prescribed for acne for decades. It... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 3, 2019 Category: General Medicine Source Type: news

New Acne Treatment Might Spring From Old One
THURSDAY, Jan. 3, 2019 -- An old acne drug may hold the key to developing a new, safer treatment, a study suggests. Isotretinoin (Myorisan, formerly branded as Accutane), is a form of vitamin A, and has been prescribed for acne for decades. It works... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 3, 2019 Category: General Medicine Source Type: news

‘Brussels sprouts drug’ could treat Alzheimer’s
Aberdeen University scientists claim they are 'moving forward with a new drug' that could treat Alzheimer's by converting vitamin A into retinoic acid, which is involved in nervous system health. (Source: the Mail online | Health)
Source: the Mail online | Health - December 24, 2018 Category: Consumer Health News Source Type: news

Retinal burns from laser pointers: a risk in children with behavioural problems - Linton E, Walkden A, Steeples LR, Bhargava A, Williams C, Bailey C, Quhill FM, Kelly SP.
OBJECTIVE: To explore self-inflicted retinal burns from laser pointers in children. METHODS: Literature review of laser pointer retinal injuries in childhood and online survey of UK Consultant Ophthalmologists. A cohort of local children with self-... (Source: SafetyLit)
Source: SafetyLit - December 19, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Scientists Find Potential New Treatment For Aggressive Blood Cancer In Eye Drops
An experimental drug being developed as an ingredient in eye drops to treat retinal disease has shown promise in treating a very aggressive type of leukemia in mice. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 19, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Gut microbiome regulates the intestinal immune system, researchers find
(Brown University) A new study in mice unveils the role of vitamin A in immune system regulation, a finding that could assist in developing treatments for autoimmune and inflammatory diseases as well as vitamin A deficiency. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 18, 2018 Category: International Medicine & Public Health Source Type: news

Eye-opening study differentiates iPS cells into various ocular lineages
(Osaka University) Osaka University researchers revealed that culturing human induced pluripotent stem cells with different isoforms of the extracellular component laminin led to the creation of cells specific to different parts of the eye, including retinal, corneal, and neural crest cells. They showed that the different laminin variants affected the cells' motility, density, and interactions, resulting in their differentiation into specific ocular cell lineages. Cells cultured in this way could be used to treat various ocular diseases. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 18, 2018 Category: Biology Source Type: news

Injection improves vision in a form of childhood blindness
(University of Pennsylvania School of Medicine) A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 17, 2018 Category: International Medicine & Public Health Source Type: news

LumiThera inks Italian Valeda distro deal
LumiThera said today that it inked a deal with ophthalmology distributor Miloftalmica to be the exclusive distributor of the Valeda light delivery system, intended to treat dry age-related macular degeneration, across Italy. Therapy using the Valeda light delivery system consists of a series of light-based treatments to the retinal cells, which Seattle-based LumiThera claims improves energy production and can be used to address inflammation, ischemia and metabolic dysfunction that contribute to the disease. “Our new exciting partnership with LumiThera is fully consistent with the strategy and growth objectives of Mil...
Source: Mass Device - December 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Optical/Ophthalmic LumiThera Source Type: news

Vitamin A is a powerful antioxidant that can slow down the process of aging
(Natural News) Taking vitamin A is not just good for improving and maintaining your eyes. It brings a host of health benefits involving many other important parts of the body. An article in Life Force Homeopathy even dubbed it the “angel vitamin” because it can keep you looking and feeling young. This underrated nutrient spurts... (Source: NaturalNews.com)
Source: NaturalNews.com - December 9, 2018 Category: Consumer Health News Source Type: news

Minimally Invasive Surgery Works Well for Detached Retina
FRIDAY, Dec. 7, 2018 -- A minimally invasive treatment for retinal detachment leads to favorable outcomes, according to a study published online Nov. 20 in Ophthalmology. Roxane J. Hillier, M.B.Ch.B., from St. Michael's Hospital and the University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 7, 2018 Category: Pharmaceuticals Source Type: news

Are Eggs Healthy? Here ’s What the Experts Say
Eggs dominate the menus of all sorts of breakfast spots, from fast-food chains to organic cafes. But the humble egg comes with a lot of questions: Will eggs raise your cholesterol? Should you order an egg-white omelet or embrace the yolks? And what about organic eggs — are they really more nutritious? Whether you eat them every day or just occasionally, there’s plenty to learn about how to incorporate eggs into a healthy diet. Here, dietitians weigh in on what you need to know about nutrition in eggs. Are eggs healthy? Nutrition experts agree that the protein and vitamins in eggs make them a healthy option. &ld...
Source: TIME: Health - December 5, 2018 Category: Consumer Health News Authors: Cassie Shortsleeve  Tags: Uncategorized Diet/Nutrition Source Type: news

Are Eggs Healthy? Here ’s What Experts Say
Eggs dominate the menus of all sorts of breakfast spots, from fast-food chains to organic cafes. But the humble egg comes with a lot of questions: Will eggs raise your cholesterol? Should you order an egg-white omelet or embrace the yolks? And what about organic eggs — are they really more nutritious? Whether you eat them every day or just occasionally, there’s plenty to learn about how to incorporate eggs into a healthy diet. Here, dietitians weigh in on what you need to know about nutrition in eggs. Are eggs healthy? Nutrition experts agree that the protein and vitamins in eggs make them a healthy option. &ld...
Source: TIME: Health - December 5, 2018 Category: Consumer Health News Authors: Cassie Shortsleeve  Tags: Uncategorized Diet/Nutrition Source Type: news

Children's Hospital celebrates European Commission approval of first-of-its-kind gene therapy for blindness
(Children's Hospital of Philadelphia) Children's Hospital of Philadelphia celebrates a pivotal moment in medicine: approval by the European Commission of LUXTURNA ® (voretigene neparvovec), the first and only gene therapy for patients with an inherited retinal disease, last month. This also makes LUXTURNA the first gene therapy for a genetic disease that has received regulatory approval in both the US and European Union. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2018 Category: International Medicine & Public Health Source Type: news

Notal Vision snags breakthrough designation for home OCT system
Ophthalmic diagnostic services company Notal Vision said it has won breakthrough device designation for its artificial-intelligence-aided macular degeneration diagnostic device. Privately-held Notal (Manassas, Va.) said its home-based optical coherence tomography (OCT) system was designed to automatically identify intra- and/or subretinal fluid in the central 10 degrees of eyes diagnosed with exudative age-related macular degeneration (eAMD). The Notal Home OCT device is intended for testing at home between regularly scheduled clinic assessments and not intended to replace standard-of-care regularly schedule...
Source: Mass Device - December 4, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Food & Drug Administration (FDA) Optical/Ophthalmic Vision Notal Vision Source Type: news

Eritrea: The Ministry of Health Eritrea Launches the National Measles Rubella Vaccination and Vitamin a Supplementation Campaign for Children Under 15
[WHO] After months of preparation, MOH together with their partners WHO and UNICEF conducted a National Measles Rubella vaccination campaign from the 19 to 30 November 2018. The launch of the event was at Asmara Community Hospital. The main objectives were to introduce new Measles Rubella vaccine, a pathway for measles elimination in the country and a proved way to minimize occurrence of neonatal rubella syndrome. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 3, 2018 Category: African Health Source Type: news

EC OKs Gene Therapy Luxturna for Inherited Retinal Dystrophy EC OKs Gene Therapy Luxturna for Inherited Retinal Dystrophy
International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 27, 2018 Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news

Clinical trial finds minimally invasive retinal detachment treatment offers patients better outcomes
(Source: St. Michael's Hospital News and Media)
Source: St. Michael's Hospital News and Media - November 27, 2018 Category: Hospital Management Tags: Hospital News Source Type: news

Novartis gets European approval for sight therapy Luxturna
Novartis on Friday said it had received European Union approval for its Luxturna gene therapy to restore sight to people with a rare retinal disease. (Source: Reuters: Health)
Source: Reuters: Health - November 23, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Researchers fighting malnutrition in Rwanda with orange sweet potatoes
Nearly half of children in Rwanda's rural communities suffer from impaired growth and vision loss, due to vitamin A deficiencies. But orange sweet potatoes, which are chock-full of vitamin A, can help. CBS News senior national correspondent Jim Axelrod reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 23, 2018 Category: Consumer Health News Source Type: news

Fighting malnutrition in Rwanda with orange sweet potatoes
The Vitamin A in orange sweet potatoes helps combat impaired growth and vision loss (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 22, 2018 Category: Consumer Health News Source Type: news

Eritrea: Launch of Measles and Rubella Vaccination Program
[Shabait] Asmara -The measles and rubella vaccination program and distribution of Vitamin A was officially launched today 21 November at a ceremony conducted at the Asmara Community Hospital in the presence of senior government officials. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 21, 2018 Category: African Health Source Type: news

Calcified Nodules in Drusen May Signal Progression of AMD
THURSDAY, Nov. 15, 2018 -- Calcified nodules in retinal drusen are linked to disease progression in patients with age-related macular degeneration (AMD), according to a study published in the Nov. 7 issue of Science Translational Medicine. Anna C.S.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 15, 2018 Category: Pharmaceuticals Source Type: news

Second Sight Medical wins final CMS reimbursement nod for Argus II
Second Sight Medical (NSDQ:EYES) said today that the Centers for Medicare & Medicaid Services finalized the outpatient payment rate for its Argus II retinal prosthesis system for the coming year. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which allows for the perception of light patterns to the brain, the Sylmar, Calif.-based company said. CMS approved a Medicare hospital outpatient payment rate of $152,500 for the Argus II system and associated procedure, with the rate set to kick in next year...
Source: Mass Device - November 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic Regulatory/Compliance Second Sight Source Type: news

Image of the Day: Retinal Transplant
Blind rats are made to see after sheets of cells implanted into their eyes make themselves at home. (Source: The Scientist)
Source: The Scientist - November 7, 2018 Category: Science Tags: Image of the Day Source Type: news

Babies are less likely to develop a milk allergy when they drink milk from cows fed a natural diet
(Natural News) Infants who have an allergic reaction to cow’s milk can benefit from those that were fed with an organic diet that is rich in retinoic acid (RA), according to researchers. The study, which was published in the journal Scientific Reports, looked the interaction between two components of cow’s milk – the vitamin A metabolite RA and the... (Source: NaturalNews.com)
Source: NaturalNews.com - November 7, 2018 Category: Consumer Health News Source Type: news

Researchers restore vision in rats after retinal cell transplant
Transplanted fetal retina cells successfully restored vision in blind rats by restoring neurons in the vision centers of their brains. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 5, 2018 Category: Consumer Health News Source Type: news

The cold and flu remedies these nine experts swear by
Dr Daniel Glass, a dermatologist on London's Harley Street, says carrots and celery in chicken soup contain beta-carotene, which supports the immune system and fight off infections. (Source: the Mail online | Health)
Source: the Mail online | Health - November 1, 2018 Category: Consumer Health News Source Type: news